Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain
- 1 December 1980
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 72 (1), 27-33
- https://doi.org/10.1007/bf00433804
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Distribution and inhibition characteristics of human brain monoamine oxidaseBiochemical Pharmacology, 1979
- Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluidJournal of Neurochemistry, 1979
- THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAINJournal of Neurochemistry, 1979
- Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differencesBiochemical Pharmacology, 1978
- MULTIPLE BINDING SITES OF HUMAN BRAIN AND LIVER MONOAMINE OXIDASE: SUBSTRATE SPECIFICITIES, SELECTIVE INHIBITIONS, AND ATTEMPTS TO SEPARATE ENZYME FORMSJournal of Neurochemistry, 1977
- STUDIES ON THE MONOAMINE OXIDASE OF MONKEY BRAINJournal of Neurochemistry, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- SUBSTRATE AND INHIBITOR‐RELATED CHARACTERISTICS OF MONOAMINE OXIDASE IN C6 RAT GLIAL CELLSJournal of Neurochemistry, 1976
- The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formationEuropean Journal of Pharmacology, 1975
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975